Thomas Kort
7Patents
2h-index
14Co-inventors
44Inventor score
Filing activity: Oct 24, 2011 → Feb 25, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8992939B2 | Highly efficient influenza matrix (M1) proteins | Chemistry; Metallurgy | 11 | Active |
| US9464276B2 | Highly efficient influenza matrix (M1) proteins | Chemistry; Metallurgy | 7 | Active |
| US11260120B2 | Immunogenic composition comprising a fusion peptide derived from superantigen toxoids | Emerging Cross-Sectional Technologies | 0 | Active |
| US9951317B2 | Highly efficient influenza matrix (M1) proteins | Chemistry; Metallurgy | 0 | Active |
| US10544399B2 | Highly efficient influenza matrix (M1) proteins | Chemistry; Metallurgy | 0 | Active |
| US11826412B2 | Immunogenic composition comprising a fusion peptide derived from superantigen toxoids | Emerging Cross-Sectional Technologies | 0 | Active |
| US11421021B2 | Immunogenic compositions comprising Staphylococcus aureus leukocidin LukA and LukB derived polypeptides | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.